# DCVax Plus Poly ICLC in Healthy Volunteers

> **NCT01127464** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 43 (actual)

## Conditions studied

- HIV-1 Infection
- HIV Infection
- Healthy Volunteers

## Interventions

- **DRUG:** DCVax-001
- **DRUG:** Poly-ICLC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01127464
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01127464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01127464, "DCVax Plus Poly ICLC in Healthy Volunteers". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01127464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*